Qlucore
The Swedish bioinformatics firm is targeting February 2025 for regulatory approval of its Qlucore Diagnostics software for transcriptomics-based ALL testing.
Qlucore Expands Into Bladder Cancer Diagnostics With Lund University Partnership
The company expects that this work to develop and validate classifier models for bladder cancer will lead to a CE mark for its Qlucore Diagnostics software platform.
Qlucore Teams With Semmelweis University on Pan-Cancer Classification
The Hungarian university will also use Qlucore's molecular diagnostics platform to improve diagnosis of acute lymphoblastic leukemia.
Immunovia Opens US Subsidiary, CLIA Lab
Sweden-based Immunovia is preparing to launch its first diagnostic — a liquid biopsy test for pancreatic cancer — in 2018.